Austria
Evologic Technologies is an Austrian-based startup, established in 2016, aiming to make science-based biologicals economically feasible. The company provides reliable contract development and manufacturing capabilities to stabilize and deliver difficult-to-produce microbial products by fermentation. It boasts leading-edge scientific expertise combined with proprietary manufacturing and formulation technologies, enabling the delivery of inherently tricky organisms reliably. Evologic's highly talented, EU-based, agile team is the core of its competitive edge, allowing the provision of highly concentrated, contaminant-free, and stable products to its customers rapidly.
The last recorded investment in Evologic Technologies was a €500.00K Debt Financing investment on 01 January 2022. The absence of disclosed investors in the latest round suggests the involvement of private or undisclosed sources. The company's operations fall within the Information Technology sector, catering to innovative firms facing challenges such as growing elusive organisms, developing scalable manufacturing processes, optimizing product quality, and supplying science-based biologicals for trials or market roll-out. Evologic's focus on overcoming these hurdles and delivering economically viable solutions positions it as an attractive prospect for potential investors in the biotechnology and agricultural technology sectors.
Evologic Technologies' unique positioning and focus on addressing critical industry pain points present significant potential for growth and impact. Its commitment to enabling the production of otherwise challenging biologicals economically could lead to disruptive advancements in various sectors, garnering interest from venture capitalists seeking opportunities in pioneering scientific endeavors.
-logo.jpg){kind=logo}
